S2-E22 - Day Two at the 4th Global NASH Congress -- many New Drugs and Non-Pharmacologic Interventions
- Author
- HEP Dynamics
- Published
- Fri 30 Apr 2021
- Episode Link
- None
Naim Alkhouri, Ian Rowe and GenFit Global Diagnostics Leader Suneil Hosmane join Louise Campbell and Roger Green to review presentations from Day Two at the 4th Global NASH Congress.
On April 29, over 175 NASH stakeholders from across the globe met virtually to hear 20 presentations from leaders in academia and industry. SurfingNASH selected 9 presentations to discuss in a session recorded right after the conference concluded. When the five panelists got together, the discussion extended to 90 minutes...too long for a single episode.
Episode 22 features Naim Alkhouri and Louise Campbell discussing featured presentations on genomics, transcriptomics and the genetics of precision medicine, plus a review of belapectin and non-hepatologist awareness of and commitment to treat NASH and NAFLD. The conversation features deep dives into drug development and debates on the proper public health strategy for treating NAFLD patients. Stimulating...engaging..."can't miss."
HEP Dynamics will publish the rest of the Day Two reviews in Episode 23 on Saturday, May 1.
